Apixaban returned to CVS Caremark formulary after outcry
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-07-01
|
| Series: | Research and Practice in Thrombosis and Haemostasis |
| Online Access: | https://doi.org/10.1002/rth2.12774 |
| _version_ | 1797758057202057216 |
|---|---|
| author | Beth Waldron |
| author_facet | Beth Waldron |
| author_sort | Beth Waldron |
| collection | DOAJ |
| first_indexed | 2024-03-12T18:24:13Z |
| format | Article |
| id | doaj.art-d7d7a07019ba462588c6645ba8c425e8 |
| institution | Directory Open Access Journal |
| issn | 2475-0379 |
| language | English |
| last_indexed | 2024-03-12T18:24:13Z |
| publishDate | 2022-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Research and Practice in Thrombosis and Haemostasis |
| spelling | doaj.art-d7d7a07019ba462588c6645ba8c425e82023-08-02T08:38:58ZengElsevierResearch and Practice in Thrombosis and Haemostasis2475-03792022-07-0165n/an/a10.1002/rth2.12774Apixaban returned to CVS Caremark formulary after outcryBeth Waldron0Independent Patient Advocate Chapel Hill North Carolina USAhttps://doi.org/10.1002/rth2.12774 |
| spellingShingle | Beth Waldron Apixaban returned to CVS Caremark formulary after outcry Research and Practice in Thrombosis and Haemostasis |
| title | Apixaban returned to CVS Caremark formulary after outcry |
| title_full | Apixaban returned to CVS Caremark formulary after outcry |
| title_fullStr | Apixaban returned to CVS Caremark formulary after outcry |
| title_full_unstemmed | Apixaban returned to CVS Caremark formulary after outcry |
| title_short | Apixaban returned to CVS Caremark formulary after outcry |
| title_sort | apixaban returned to cvs caremark formulary after outcry |
| url | https://doi.org/10.1002/rth2.12774 |
| work_keys_str_mv | AT bethwaldron apixabanreturnedtocvscaremarkformularyafteroutcry |